Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shaoyao Shujing
- Development stage
- Unknown
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shaoyao Shujing is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Guangdong Provincial Hospital of Chinese Medicine, specifically formulated as a tablet for the treatment of knee osteoarthritis. The name "Shaoyao" refers to the primary ingredient, *Paeonia lactiflora* (Peony), which is traditionally used in Chinese medicine for its analgesic, anti-inflammatory, and antispasmodic properties. "Shujing" translates to "relaxing the tendons," reflecting its clinical use in alleviating joint stiffness and pain. The drug has been evaluated in clinical trials using magnetic resonance imaging (MRI) to assess its impact on joint structure and symptom relief in patients with early-stage knee osteoarthritis. It is typically classified as a hospital preparation (医院制剂) in China.
- Other names
- Shaoyao Shujing tabletShaoyao Shujing pian
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HSD11B2 (11β-HSD2)ESR2 (ERβ)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Shaoyao Shujing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shaoyao Shujing.